Browse our anti-FOXM1 (FOXM1) Antibodies

Human Forkhead Box M1 (FOXM1) interaction partners

1. miR-361-5p acts as a tumor suppressor in lung cancer through down-regulation of FOXM1.

2. Knockdown of GTSE1 obviously suppressed the proliferation, migration, and invasion capacity whereas increasing GTSE1 led to the opposite trend, which suggested that GTSE1 could serve as a potential therapeutic target for bladder cancer. GTSE1 overexpression in bladder cancer might participate in the regulation of FoxM1/CCNB1 expression via the induction of the transfer of p53 to cytoplasm

3. FOXM1c promotes the metastasis by transcriptionally targeting IRF1 and may serve as a potential prognostic predictor for oesophageal cancer.

4. Our data demonstrated the critical role of FoxM1 in promoting gastrointestinal stromal tumor progression and uncovered a novel HIF-1alpha/HIF-2alpha-FoxM1 axis

5. Patients with FOXM1 overexpression may exhibit an increased risk of lymphatic metastatic recurrence (LMR) and poor prognosis. FOXM1 may serve as a potential biomarker to predict the LMR in stage IIA esophageal squamous cell carcinoma.

6. Study identified that FOXM1 regulates certain cell cycle genes and affects triplenegative breast cancer (TNBC) proliferation. The pathway analysis demonstrated that FOXM1 is highly associated with multiple biological processes in the network.

7. Transcription factor forkhead box M1 (FOXM1) message is elevated in most but not all relapsed myelomas.

8. Overexpression of FOXM1 might be associated with shorter overall survival of Chinese non-small cell lung cancer patients.[meta-analysis]

9. Data identify miR-6868-5p as a novel determinant of FOXM1 expression and establish a miR-6868-5p/FOXM1 regulatory circuit for CRC angiogenesis.

10. KIAA0101 was closely related to the FOXM1 and PI3K/AKT/mTOR signaling pathways.

11. FOXM1 knockdown reduced cell viability, migration, and invasion by propofol treatment plus miR-1284 suppression. In conclusion, our study indicated that propofol could inhibit cell viability, migration, invasion, and the EMT process in lung cancer cells by regulation of miR-1284.

12. An association between the gene expression signature of FOXM1 and hepatocellular carcinoma patient outcome.FOXM1 is a key regulator of genes associated with patient survival.

13. the role of Spalt like protein 4 (SALL4) in pancreatic ductal adenocarcinoma cell proliferation, mobility and its regulation in mitochondrial ROS via FoxM1/Prx III axis.

14. ADAM-17 is an independent prognostic marker for patients with hilar cholangiocarcinoma. FoxM1 regulates the expression of ADAM-17 and then induced TNFa production and cleavage.

15. The tumour suppressive roles of miR8765p overexpression in GBM cells were significantly reversed by FOXM1 reintroduction.

16. Data show that forkhead box protein M1 (FoxM1) enhanced carboplatin resistance in Y-79CR cells through directly up-regulating the transcription of ATP-binding cassette transporter C4 (ABCC4).

17. FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence.

18. TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

19. Studies indicate that the oncogene forkhead box protein M1 (FoxM1) has emerged as an important molecule implicated in initiation, development and progression of cancer [Review].

20. These findings revealed the role of forkhead box M1 upregulation by manganese superoxide dismutase overexpression in maintaining lung cancer stem-like cell properties. Therefore, inhibition of forkhead box M1 upregulation by manganese superoxide dismutase overexpression may represent an effective therapeutic strategy for non-small cell lung cancer.

Mouse (Murine) Forkhead Box M1 (FOXM1) interaction partners

1. vagal signal-mediated interleukin-6 production in hepatic macrophages upregulates hepatocyte FoxM1, leading to liver regeneration and assures survival.

2. Vagal signals activate the forkhead box M1 (FoxM1) pathway in beta-cells, resulting in compensatory beta-cell proliferation. Inducible beta-cell-specific FoxM1 deficiency also blocks compensatory beta-cell proliferation.

3. Disrupting LXRalpha phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation

4. Upregulated ROS induced by FABP4 was of significance in activating FoxM1 leading to airway inflammation and epithelial barrier dysfunction.

5. Interactions between the Wnt/beta-catenin and the Kras/ERK/Foxm1 pathways are essential to restrict SOX9 expression in basal cells during pulmonary branching morphogenesis

6. YAP cooperates with FOXM1 to contribute to chromosome instability in hepatocellular carcinoma.

7. RCM-1 blocked the nuclear localization and increased the proteasomal degradation of Forkhead box M1 (FOXM1), a transcription factor critical for the differentiation of goblet cells from airway progenitor cells.

8. These data implicate the insulin-FoxM1/PLK1/CENP-A pathway-regulated mitotic cell-cycle progression as an essential component in the beta cell adaptation to delay and/or prevent progression to diabetes.

9. EGF promotes FoxM1 expression through the ERK signal pathway

10. FoxM1 induction in the pulmonary vasculature was inhibited by a p110gamma-selective inhibitor and in Pik3cg(-/-) mice after LPS challenge. Defective vascular repair in Pik3cg-/- mice results from impaired FoxM1 expression

11. we suggest that proper regional decidualization and polyploidy development requires FoxM1 signaling downstream of Hoxa10 and cyclin D3.

12. FOXM1 and CENPF are master regulators of prostate cancer malignancy, and can serve as drug response markers for antineoplastic drugs efficiency.

13. Both gain-of-function and loss-of-function TP53 mutations contribute to overexpression of FoxM1 in high-grade serous ovarian cancer.

14. MicroRNA-802 suppresses breast cancer proliferation through down-regulation of FoxM1.

15. FoxM1 expression correlates with proliferation, invasion and migration in mouse hepatocellular carcinoma cell lines.

16. null mice have reductions in both the somatotrope and gonadotrope cell populations.

17. activated FoxM1 increases beta-cell replication while simultaneously enhancing insulin secretion and improving glucose homeostasis, making FoxM1 an attractive therapeutic target for diabetes.

18. Data indicate transcription factor Foxm1 as a critical regulator of the quiescence and self-renewal of hematopoietic stem cells (HSCs).

19. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.

20. FoxM1 might play an important role during the process of mouse embryo implantation.

Xenopus laevis Forkhead Box M1 (FOXM1) interaction partners

1. the sequence and expression pattern of FoxM1 (fork head box M1) transcription factor in Xenopus laevis embryos are described

2. Results suggest that FoxM1 functions to link cell division and neuronal differentiation in early Xenopus embryos.